Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
Acta Paediatr ; 101(9): e411-5, 2012 Sep.
Article in English | MEDLINE | ID: mdl-22578243

ABSTRACT

AIM: To investigate malabsorption of lactose and fructose as causes of recurrent abdominal pain (RAP). METHODS: In 220 children (128 girls, mean age 8,8 [4.1-16.0] years) with RAP, hydrogen breath tests (H(2) BT; abnormal if ΔH(2) > 30 ppm) were performed with lactose and fructose. Disappearance of RAP with elimination, recurrence with provocation and disappearance with re-elimination, followed by a 6-month pain-free follow-up, were considered indicative of a causal relation with RAP. For definite proof, a double-blinded placebo-controlled (DBPC) provocation was performed. RESULTS: Malabsorption of lactose was found in 57 of 210, of fructose in 79 of 121 patients. Pain disappeared upon elimination in 24/38 patients with lactose malabsorption, and in 32/49 with fructose malabsorption. Open provocation with lactose and fructose was positive in 7/23 and 13/31 patients. DBPC provocation in 6/7 and 8/13 patients was negative in all. However, several children continued to report abdominal symptoms upon intake of milk or fructose. CONCLUSION: Lactose intolerance nor fructose intolerance could be established as causes of RAP, according to preset criteria including elimination, open provocation and DBPC provocation. However, in clinical practice, persistent feeling of intolerance in some patients should be taken seriously and could warrant extended elimination with repeated challenges.


Subject(s)
Abdominal Pain/etiology , Fructose Metabolism, Inborn Errors/complications , Lactose Intolerance/complications , Abdominal Pain/metabolism , Adolescent , Breath Tests , Child , Child, Preschool , Chronic Disease , Double-Blind Method , Female , Fructose Metabolism, Inborn Errors/metabolism , Humans , Hydrogen/metabolism , Lactose Intolerance/metabolism , Male , Recurrence
2.
Acta Paediatr ; 100(11): e208-14, 2011 Nov.
Article in English | MEDLINE | ID: mdl-21575052

ABSTRACT

AIM: To establish to what extent somatic causes can be found in children referred to secondary care with recurrent abdominal pain. METHODS: For 2 years, all consecutive patients (age 4-16 years) fulfilling Apley criteria, referred to secondary care, were included. After a diagnostic work-up, stepwise therapeutic interventions were performed. A diagnosis was considered to be the cause of the pain when the patient became pain free following therapeutic intervention and remained so for at least 6 months. RESULTS: Two hundred and twenty children (128 F, 92 M; mean age 8.8 years) were enrolled, of which 20 were lost to follow-up. Spontaneous recovery was seen in 54 patients, (occult) constipation in 92 patients (of whom 18 also had a somatic cause), gastrointestinal infections in 40, food allergy in five, miscellaneous disorders in seven and uncertain diagnosis in 13. In five patients, stress most likely caused the pain. A total of 198 patients became pain free and remained so during follow-up (mean 18, range 6-60 months). CONCLUSION: In 200 children with recurrent abdominal pain, somatic causes were found in 26%. Laxative therapy was successful in 46%, resulting in nearly all patients with functional abdominal pain to become pain free. Eventually, 99% became pain free using a therapeutic intervention protocol.


Subject(s)
Abdominal Pain/etiology , Constipation/complications , Food Hypersensitivity/complications , Gastrointestinal Diseases/complications , Abdominal Pain/diagnosis , Abdominal Pain/therapy , Adolescent , Child , Child, Preschool , Constipation/diagnosis , Constipation/therapy , Diet Therapy , Female , Food Hypersensitivity/diagnosis , Food Hypersensitivity/therapy , Gastrointestinal Diseases/diagnosis , Gastrointestinal Diseases/therapy , Humans , Laxatives/therapeutic use , Male , Recurrence
3.
Acta Paediatr ; 100(7): 1028-32, 2011 Jul.
Article in English | MEDLINE | ID: mdl-21272071

ABSTRACT

AIM: To investigate the clinical and laboratory findings in children with recurrent abdominal pain (RAP). METHODS: Consecutive patients with RAP (Apley criteria), age 4-16 years, referred to a secondary medical centre were evaluated by a standardized history, physical examination and laboratory tests. The tests encompassed Helicobacter pylori (Hp), gastrointestinal bacterial infections, protozoa, coeliac disease, carbohydrate malabsorption, food intolerance, abdominal ultrasound and plain abdominal X-ray. More investigations were obtained if indicated. Patient characteristics were compared with surgical patients without abdominal pain (control group). RESULTS: A total of 220 consecutive patients were included (92 M, mean age 8.8 years [4.1-16.0 years]). In 88% of the patients, abnormalities were found that refer to possible causes. Especially, protozoa were present in 33% of the patients, mostly Dientamoeba fragilis, Yersinia enterocolitica in 12% and endoscopically proven infection with Hp in 11%. In 36%, a plain abdominal X-ray raised suspicion of constipation. CONCLUSION: In 220 consecutive patients with RAP, referred to secondary care, a standardized work-up yielded abnormal results in a high percentage. The clinical significance of these findings remains to be established.


Subject(s)
Abdominal Pain/etiology , Constipation/complications , Dientamoebiasis/complications , Helicobacter Infections/complications , Yersinia Infections/complications , Abdominal Pain/microbiology , Abdominal Pain/parasitology , Adolescent , Case-Control Studies , Child , Child, Preschool , Dientamoeba/classification , Dientamoeba/isolation & purification , Endoscopy, Gastrointestinal , Female , Helicobacter pylori/isolation & purification , Humans , Male , Prospective Studies , Radiography, Abdominal , Recurrence , Referral and Consultation , Yersinia enterocolitica/isolation & purification
4.
Aliment Pharmacol Ther ; 33(2): 243-50, 2011 Jan.
Article in English | MEDLINE | ID: mdl-21083595

ABSTRACT

BACKGROUND: Infliximab is effective for induction and maintenance of remission in children with moderately to severely active Crohn's disease (CD). AIM: To evaluate the long-term efficacy of infliximab treatment in paediatric CD. METHODS: In this observational, multicentre study, all paediatric CD patients in The Netherlands treated with infliximab from October 1992 to November 2009 and with minimal follow-up of 3 months since start of infliximab, were studied. RESULTS: One hundred and fifty-two CD patients [81M; median age at start of infliximab 15.0 years (IQR 13.1-16.4)] received a median number of 10.5 infliximab infusions (IQR 6-21). Median follow-up after start of infliximab was 25 months (IQR 13-40). Kaplan-Meier analysis showed that the cumulative probability of losing response to infliximab in patients who initially required repeated infusions was 13%, 40% and 50% after 1, 3 and 5 years, respectively. Seventy-four patients (49%) needed dose adjustments, with a median time to any adjustment of 6 months. CONCLUSIONS: Duration of effect of infliximab is limited as 50% of patients on infliximab maintenance treatment lose their therapeutic response after 5 years. Dose adjustments after start of infliximab are frequently needed to regain therapeutic benefit. These findings emphasise the need for effective, long-term treatment strategies for paediatric CD.


Subject(s)
Antibodies, Monoclonal/therapeutic use , Gastrointestinal Agents/therapeutic use , Adolescent , Child , Crohn Disease/drug therapy , Female , Follow-Up Studies , Humans , Infliximab , Male , Netherlands , Time Factors , Treatment Outcome
5.
Pediatr Res ; 37(2): 213-8, 1995 Feb.
Article in English | MEDLINE | ID: mdl-7731760

ABSTRACT

The incidence and prevalence of celiac disease vary internationally. We studied the incidence of identified cases of childhood celiac disease in six Dutch provinces that cover 47.9% of the surface area and 67.6% of the total population of The Netherlands. Children with celiac disease aged 0-14 y, diagnosed from January 1975 to January 1991, were traced by 1) contacting all pediatricians in this area, 2) examining the date of the Dutch National Medical Registration, and 3) investigating the membership records of the Dutch Celiac Disease Society. These data were cross-checked by the Dutch Network and National Database of Pathology. Of the 97.9% of pediatricians who answered our inquiry, 46.1% were treating celiac patients. A total of 342 celiac patients were identified. Informed consent that permitted examination of their medical files was given by 97.3% of the parents of the celiac children. The mean crude incidence rate of diagnosed childhood celiac disease, calculated per 1000 live births per year, was 0.18. However, a significant increase in reported incidence was demonstrated from 0.10 in 1976 to 0.32 in 1990. The best estimate, for the years 1985-1990, is 0.22/1000 live births, which is much lower than in most European countries.


Subject(s)
Celiac Disease/epidemiology , Adolescent , Biopsy/statistics & numerical data , Celiac Disease/diagnosis , Celiac Disease/genetics , Celiac Disease/pathology , Child , Child, Preschool , Female , Genetic Predisposition to Disease , HLA-D Antigens/analysis , Humans , Incidence , Infant , Infant, Newborn , Intestine, Small/pathology , Male , Netherlands/epidemiology , Prevalence
6.
Eur Heart J ; 15(11): 1545-51, 1994 Nov.
Article in English | MEDLINE | ID: mdl-7835370

ABSTRACT

UNLABELLED: Left atrial spontaneous echo contrast, detected by transoesophageal echocardiography in patients with non-valvular atrial fibrillation reflects slow blood flow and is associated with an increased risk of cardio-embolism. The purpose of this study was to find echo/Doppler predictors of left atrial spontaneous echo contrast by transthoracic examination. In a retrospective case control study, 17 patients with chronic non-valvular atrial fibrillation who had suffered a recent cerebral ischaemic event (group A) and 17 patients with chronic non-valvular atrial fibrillation who had not suffered such an event (group B) were studied. Both groups were matched for age and sex. All patients underwent standard transthoracic echocardiography with transmitral Doppler as well as transoesophageal echocardiography. Left atrial spontaneous echo contrast was demonstrated by transoesophageal echocardiography in nine group A patients and in two group B patients (P = 0.028); left atrial spontaneous echo contrast was not detected by transthoracic echocardiography in these patients. All patients with left atrial spontaneous echo contrast (11 patients) had a left atrial size, corrected for base index, exceeding 24 mm and a transmitral time velocity integral < 10 cm (sensitivity 100%). Left atrial spontaneous echo contrast was absent in six patients with both characteristics (specificity 74%). CONCLUSION: transthoracic echo/Doppler aids in the prediction of the presence of left atrial spontaneous echo contrast and the identification of patients with non-valvular atrial fibrillation with increased cardioembolic risk, thus avoiding transoesophageal echocardiography.


Subject(s)
Atrial Fibrillation/diagnostic imaging , Echocardiography/methods , Heart Atria/diagnostic imaging , Thromboembolism/prevention & control , Aged , Atrial Fibrillation/complications , Brain Ischemia/complications , Chronic Disease , Echocardiography, Doppler, Pulsed , Echocardiography, Transesophageal , Female , Humans , Male , Middle Aged , Retrospective Studies , Sensitivity and Specificity , Thromboembolism/etiology
7.
Neurosurgery ; 19(3): 446-8, 1986 Sep.
Article in English | MEDLINE | ID: mdl-3762894

ABSTRACT

A patient is reported who had spontaneous resolution of an acute traumatic subdural hematoma within 6 hours. In this period, clinical signs improved and computed tomography suggested disappearance of the hematoma. Magnetic resonance imaging demonstrated no real disappearance, but rather a redistribution of the blood. A rapid resolution like this has not been observed previously in the natural history of acute subdural hematoma.


Subject(s)
Hematoma, Subdural/metabolism , Acute Disease , Female , Humans , Middle Aged , Remission, Spontaneous
SELECTION OF CITATIONS
SEARCH DETAIL
...